Plant ID: NPO23270
Plant Latin Name: Neolitsea daibuensis
Taxonomy Genus: Neolitsea
Taxonomy Family: Lauraceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
TAS2R31; | |
TSHR; | |
FAAH; TERT; | |
PPARA; PPARD; PPARG; | |
ALDH2; | |
FABP5; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Enzyme_unclassified | FAAH | Anandamide amidohydrolase | O00519 | CHEMBL2243 |
Enzyme_unclassified | TERT | Telomerase reverse transcriptase | O14746 | CHEMBL2916 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Nuclear hormone receptor subfamily 1 group C | PPARG | Peroxisome proliferator-activated receptor gamma | P37231 | CHEMBL235 |
Oxidoreductase | ALDH2 | Aldehyde dehydrogenase | P05091 | CHEMBL1935 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Taste receptor (taste family GPCR) | TAS2R31 | Taste receptor type 2 member 31 | P59538 | CHEMBL2034804 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0009987; cellular process | GO:0009755; hormone-mediated signaling pathway | 6.566E-07 | 4.766E-03 | PPARA, PPARD, PPARG, TSHR |
MF | GO:0140110; transcription regulator activity | GO:0004879; nuclear receptor activity | 1.275E-06 | 5.552E-03 | PPARA, PPARD, PPARG |
BP | GO:0051179; localization | GO:0010891; negative regulation of sequestering of triglyceride | 1.928E-06 | 6.534E-03 | PPARA, PPARG |
BP | GO:0051179; localization | GO:0010887; negative regulation of cholesterol storage | 2.892E-06 | 6.534E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0010871; negative regulation of receptor biosynthetic process | 2.892E-06 | 6.534E-03 | PPARA, PPARG |
BP | GO:0051179; localization | GO:0015908; fatty acid transport | 3.301E-06 | 6.534E-03 | PPARA, PPARD, PPARG |
MF | GO:0060089; molecular transducer activity | GO:0003707; steroid hormone receptor activity | 2.244E-06 | 6.534E-03 | PPARA, PPARD, PPARG |
BP | GO:0008152; metabolic process | GO:0006631; fatty acid metabolic process | 6.409E-06 | 1.073E-02 | FAAH, PPARA, PPARD, PPARG |
BP | GO:0008152; metabolic process | GO:1902894; negative regulation of pri-miRNA transcription from RNA polymerase II promoter | 1.059E-05 | 1.537E-02 | PPARA, PPARD |
MF | GO:0005488; binding | GO:0036041; long-chain fatty acid binding | 1.059E-05 | 1.537E-02 | PPARD, PPARG |
MF | GO:0005488; binding | GO:0001223; transcription coactivator binding | 3.651E-05 | 2.564E-02 | PPARA, TERT |
MF | GO:0005488; binding | GO:0008134; transcription factor binding | 9.606E-05 | 4.613E-02 | PPARA, PPARD, PPARG, TERT |
CC | GO:0043226; organelle | GO:0005654; nucleoplasm | 6.738E-03 | 5.419E-01 | FABP5, PPARA, PPARD, PPARG, TERT |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 1.613E-08 | 5.808E-07 | FABP5, PPARG, PPARA, PPARD |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04024 | cAMP signaling pathway | 3.387E-03 | 5.249E-02 | PPARA, TSHR |
09160 Human Diseases | 09161 Cancers | hsa05200 | Pathways in cancer | 1.290E-02 | 5.249E-02 | PPARG, PPARD |
09100 Metabolism | 09105 Amino acid metabolism | hsa00340 | Histidine metabolism | 1.075E-02 | 5.249E-02 | ALDH2 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00053 | Ascorbate and aldarate metabolism | 1.209E-02 | 5.249E-02 | ALDH2 |
09160 Human Diseases | 09161 Cancers | hsa05216 | Thyroid cancer | 1.298E-02 | 5.249E-02 | PPARG |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 2.536E-02 | 5.249E-02 | PPARD |
09150 Organismal Systems | 09152 Endocrine system | hsa04923 | Regulation of lipolysis in adipocytes | 2.492E-02 | 5.249E-02 | TSHR |
09160 Human Diseases | 09162 Immune diseases | hsa05320 | Autoimmune thyroid disease | 2.360E-02 | 5.249E-02 | TSHR |
09100 Metabolism | 09103 Lipid metabolism | hsa00561 | Glycerolipid metabolism | 2.624E-02 | 5.249E-02 | ALDH2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Alcohol use disorders | F10.2 | ALDH2; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Substance dependence | F10-F19 | ALDH2; |
I00-I99: Diseases of the circulatory system | Cerebrovascular ischaemia | I61-I63 | ALDH2; |